H1N1VACCINATION.US

Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine , despite its history of use in other countries. … The senators recommend that Avandia be pulled from the market because its risks seem to outweigh its benefits , especially compared to other diabetes drugs, such as Takeda’s Actos, which lower blood-sugar level but don’t affect the heart as much, according to studies. …

Read the original post:
Bad science kills & injures – US Message Board – Political …

Vaccines are a major public health triumph and any risks are far outweighed by benefits . That was made depressingly clear three years ago in the US when Gardasil, Merck’s Human Papillomavirus vaccine , came on the market. … I recently asked the question about H1N1 vaccine effectiveness of the world’s leading authority on the quality of the evidence supporting influenza vaccines, Dr Tom Jefferson, a medically trained epidemiologist who has been a reviewer for the Cochrane …

Originally posted here:
Correcting the record on swine flu vaccination stories – Croakey

The summer of 2009 revealed two inconvenient truths about vaccination . First, the Gardasil vaccine is not as safe as the government, medical organizations and Merck have said it is. Second, the H1N1 influenza pandemic is not as serious as health officials …. In my opinion, the potential risks of Gardasil FAR outweigh the perception of ANY potential benefits , and the HPV vaccine , and next to hepatitis B vaccine , it is one of the most unnecessary vaccines on the market. …

Read more from the original source:
LibNOT – News, Video, and Conservative Opinion » Gardasil and …